EFDID: 254018EFD: View Filing

Issuer: Kalytera Therapeutics, Inc. (0001639643) - D

Accession: 0001639643-18-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Kalytera Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    BRITISH COLUMBIA, CANADA
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    41 THUNDERBIRD DRIVE
    NOVATO, CA 94949
  • Persons:
    Related Persons 7
    ROBERT FARRELL
    Executive Officer, Director
    RONALD ERICKSON
    Director
    GARY LEONG
    Director
    JEFF PALEY
    Director
    SARI PRUTCHI-SAGIV
    Executive Officer
    MOSHE YESHURUN
    Executive Officer
    RONEN RAVIV
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    01/03/2018
  • First Sale Date:
    12/20/2017
  • Offering Amount:
    $200,000
  • Amount Sold:
    $200,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Units (convertible debentures and warrants to purchase common shares)
  • Sales Clarification:
    Estimated amount based on a $CAD1.25/$USD1.00 exchange rate
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
ECHELON WEALTH PARTNERS INC. None LEK SECURITIES CORP. 33135 NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Kalytera Therapeutics, Inc./s/ Robert FarrellRobert FarrellPresident, CEO and Director2018-01-03